What Peptide Purity Testing Actually Measures
A purity figure on a peptide specification sheet is almost always chromatographic purity: the area of the main peak expressed as a percentage of the total integrated peak area in a reverse-phase HPLC run. It is a statement about how the sample behaves on one column under one gradient, detected at one wavelength. Every other property of the material, including how much peptide is actually in the vial, comes from a different method entirely.
Peptide testing is a set of methods, not a single test. The number quoted most often is relative: reverse-phase HPLC separates the sample in time, a UV detector records absorbance, software integrates the resulting curve, and the main peak's area is divided by the sum of all integrated areas. A result of 98.6 percent by RP-HPLC area at 214 nm means the main peak carried 98.6 percent of the absorbance that the method detected. It does not mean 98.6 percent of the powder is peptide.
That distinction matters because the remaining mass in a vial is rarely a single contaminant. Lyophilized synthetic peptide typically carries bound water, a counterion left from the purification step, residual organic solvent, and any excipient added as a bulking agent. None of those absorb strongly at 214 nm, so none of them appear in the chromatographic figure at all.
A specification sheet is therefore read method by method. What follows is what each method measures, in what unit, and what it is silent about.
The four questions, and the method for each
| Question | Method | Reported unit | Silent about |
|---|---|---|---|
| How much of the detected material is the main species? | RP-HPLC, gradient elution, UV detection at 214 nm | Area percent of total integrated peak area | Anything without a chromophore at 214 nm |
| Is the main species the intended sequence? | ESI or MALDI mass spectrometry | Observed mass in Da against calculated mass | Relative quantity of each species |
| How much peptide is in the container by mass? | Amino acid analysis after acid hydrolysis, or nitrogen determination | Percent net peptide content, w/w | Which impurities make up the balance |
| How much water is bound to the solid? | Karl Fischer coulometric titration | Percent water, w/w | Whether that water is surface bound or structural |
| What solvent is left from synthesis and purification? | Headspace gas chromatography against ICH Q3C limits | Parts per million per named solvent | Non-volatile residues |
Read together, those five rows describe a lot. Read in isolation, any one of them can be made to sound like a complete characterisation, which is why the method and the wavelength belong beside the number every time it is printed.
Why 214 nm and not 280 nm
214 nm is close to the absorbance maximum of the amide bond itself, so every residue in the backbone contributes. 280 nm detects the aromatic side chains of tryptophan, tyrosine and, weakly, phenylalanine. A sequence with no aromatic residue is close to invisible at 280 nm and perfectly visible at 214 nm, so the wavelength is not an arbitrary instrument setting: it decides which impurities are counted.
The trade is sensitivity against selectivity. At 214 nm the detector also responds to trifluoroacetate, to solvent fronts and to almost any peptide-related fragment, so baseline handling and the integration window become part of the result. Two laboratories running the same sample with different gradient lengths and different integration thresholds can report figures that differ by a few tenths of a percent without either being wrong.
The failure mode: co-elution under one peak
The characteristic way a chromatographic purity figure overstates a material is co-elution. A deletion sequence missing one residue, or a diastereomer formed by racemisation at a single centre, can be chemically distinct and chromatographically identical under a shallow gradient. Both species sit inside the same peak, the integration counts them as one, and the number comes back high.
It shows up as a peak that is subtly asymmetric, a shoulder that appears when the gradient is lengthened, or a mass spectrum with a second signal offset from the target by the mass of the missing residue. The diagnostic is orthogonality: a second separation on a different stationary phase, a different mobile-phase pH, or a mass-selective detector. A single method run once is never evidence of homogeneity.
What the number cannot reach
Chromatographic purity is a chemical measurement. It carries no information about the microbiological state of the material, because viable organisms are not chromophores and do not elute. Bioburden, sterility and bacterial endotoxin are three further and entirely separate questions, addressed by USP general chapters 61, 71 and 85 respectively, each with its own sample handling and its own unit of measure.
- Area percent by RP-HPLC is relative to what the detector saw, not to the mass in the vial.
- Net peptide content is a mass fraction and requires amino acid analysis or nitrogen determination.
- Water content by Karl Fischer is reported separately and is often the largest single non-peptide component.
- Counterion content, commonly trifluoroacetate or acetate, is its own determination by ion chromatography or fluorine analysis.
- Microbiological attributes are not covered by any chemical purity method.
Where the published record stops
Material listed by Aurum is independently assayed for purity by reverse-phase HPLC, and identity is assayed by mass spectrometry. Those are the two figures published. The purity figure is HPLC purity and not net peptide content, which Aurum does not publish, so it should not be read as a mass fraction. Sterility, endotoxin and pyrogen testing are not performed and not claimed, and nothing published describes the material as sterile or as endotoxin controlled.
Net peptide content, water content, counterion content and residual solvent are not among the specifications Aurum publishes. Where a figure is absent, the correct reading is that it is not published, not that it was determined and passed. A published purity figure is also a measurement at one point in time on one sample, and it does not forecast the same material's chromatogram after a period of storage under unknown conditions.
Common questions
Is a higher purity figure always a better material?
Not on its own. A high area percent obtained under a method with poor resolving power carries less information than a slightly lower figure obtained under a gradient that separates close-running impurities. The method description is doing as much work as the number.
Why do two certificates disagree on the same lot?
Different columns, gradient slopes, sample loading, detection wavelengths and integration thresholds. Disagreement of a few tenths of a percent between laboratories is ordinary. Disagreement of several percent usually points at a different integration window or a different wavelength rather than a different material.
Does purity testing detect water?
No. Water has no absorbance at 214 nm in this context and does not produce a peak. Residual moisture is a separate coulometric determination.
What is the single most informative addition to a chromatographic figure?
A net peptide content determination, because it converts a relative number into a mass fraction and closes the gap between area percent and what is physically in the container.
References
- 01United States Pharmacopeia General Chapter <621> Chromatography. USP–NF.
- 02United States Pharmacopeia General Chapter <1057> Biotechnology-Derived Articles - Amino Acid Analysis. USP–NF.
- 03United States Pharmacopeia General Chapter <921> Water Determination. USP–NF.
- 04International Council for Harmonisation ICH Q3C(R8) Impurities: Guideline for Residual Solvents. ICH, 2021.
- 05International Council for Harmonisation ICH Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. ICH, 1999.
- 06European Pharmacopoeia General Chapter 2.2.29 Liquid Chromatography. Ph. Eur..
Every citation links out to the paper on PubMed. Identifiers are omitted deliberately rather than reproduced from memory, so where we do not hold a verified PMID or DOI the link is a PubMed search for that exact title — it resolves to the paper without anything being invented.
FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN CONSUMPTION. This article describes compounds and the research literature in which they appear. Nothing here is a recommendation, protocol, or statement of effect.